ONECUT2: ATargetable Master Regulator of Progression to Neuroendocrine Differentiation from Prostate Adenocarcinoma

被引:0
|
作者
Rotinen, Mirja [1 ]
You, Sungyong [1 ]
Yang, Julie [1 ]
Coetzee, Simon [1 ]
Huang, Wen-Chin [1 ,2 ]
Huang, Fangjin [1 ]
Pan, Xinlei [1 ]
Yanez, Alberto [1 ]
Hazelett, Dennis [1 ]
Chu, Chia-Yi [1 ]
Chung, Leland [1 ]
Di Vizio, Dolores [1 ]
Garraway, Isla [3 ]
Murali, Ramachandran [1 ]
Knudsen, Beatrice [1 ]
Freeman, Michael [1 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] China Med Univ, Taichung, Taiwan
[3] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:353 / 354
页数:2
相关论文
共 50 条
  • [1] ONECUT2 is a driver of neuroendocrine prostate cancer
    Haiyang Guo
    Xinpei Ci
    Musaddeque Ahmed
    Junjie Tony Hua
    Fraser Soares
    Dong Lin
    Loredana Puca
    Aram Vosoughi
    Hui Xue
    Estelle Li
    Peiran Su
    Sujun Chen
    Tran Nguyen
    Yi Liang
    Yuzhe Zhang
    Xin Xu
    Jing Xu
    Anjali V. Sheahan
    Wail Ba-Alawi
    Si Zhang
    Osman Mahamud
    Ravi N. Vellanki
    Martin Gleave
    Robert G. Bristow
    Benjamin Haibe-Kains
    John T. Poirier
    Charles M. Rudin
    Ming-Sound Tsao
    Bradly G. Wouters
    Ladan Fazli
    Felix Y. Feng
    Leigh Ellis
    Theo van der Kwast
    Alejandro Berlin
    Marianne Koritzinsky
    Paul C. Boutros
    Amina Zoubeidi
    Himisha Beltran
    Yuzhuo Wang
    Housheng Hansen He
    Nature Communications, 10
  • [2] ONECUT2 is a driver of neuroendocrine prostate cancer
    Guo, Haiyang
    Ci, Xinpei
    Ahmed, Musaddeque
    Hua, Junjie Tony
    Soares, Fraser
    Lin, Dong
    Puca, Loredana
    Vosoughi, Aram
    Xue, Hui
    Li, Estelle
    Su, Peiran
    Chen, Sujun
    Tran Nguyen
    Liang, Yi
    Zhang, Yuzhe
    Xu, Xin
    Xu, Jing
    Sheahan, Anjali V.
    Ba-Alawi, Wail
    Zhang, Si
    Mahamud, Osman
    Vellanki, Ravi N.
    Gleave, Martin
    Bristow, Robert G.
    Haibe-Kains, Benjamin
    Poirier, John T.
    Rudin, Charles M.
    Tsao, Ming-Sound
    Wouters, Bradly G.
    Fazli, Ladan
    Feng, Felix Y.
    Ellis, Leigh
    van der Kwast, Theo
    Berlin, Alejandro
    Koritzinsky, Marianne
    Boutros, Paul C.
    Zoubeidi, Amina
    Beltran, Himisha
    Wang, Yuzhuo
    He, Housheng Hansen
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [3] ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
    Rotinen, Mirja
    You, Sungyong
    Yang, Julie
    Coetzee, Simon G.
    Reis-Sobreiro, Mariana
    Huang, Wen-Chin
    Huang, Fangjin
    Pan, Xinlei
    Yanez, Alberto
    Hazelett, Dennis J.
    Chu, Chia-Yi
    Steadman, Kenneth
    Morrissey, Colm M.
    Nelson, Peter S.
    Corey, Eva
    Chung, Leland W. K.
    Freedland, Stephen J.
    Di Vizio, Dolores
    Garraway, Isla P.
    Murali, Ramachandran
    Knudsen, Beatrice S.
    Freeman, Michael R.
    NATURE MEDICINE, 2018, 24 (12) : 1887 - +
  • [4] ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
    Mirja Rotinen
    Sungyong You
    Julie Yang
    Simon G. Coetzee
    Mariana Reis-Sobreiro
    Wen-Chin Huang
    Fangjin Huang
    Xinlei Pan
    Alberto Yáñez
    Dennis J. Hazelett
    Chia-Yi Chu
    Kenneth Steadman
    Colm M. Morrissey
    Peter S. Nelson
    Eva Corey
    Leland W. K. Chung
    Stephen J. Freedland
    Dolores Di Vizio
    Isla P. Garraway
    Ramachandran Murali
    Beatrice S. Knudsen
    Michael R. Freeman
    Nature Medicine, 2018, 24 : 1887 - 1898
  • [5] ONECUT2 is a targetable master regulator of aggressive variants of castration-resistant prostate
    Rotinen, Mirja
    You, Sungyong
    Yang, Julie
    Coetzee, Simon
    Huang, Wen-Chin
    Huang, Fangjin
    Pan, Xinlei
    Yanez, Alberto
    Hazelett, Dennis
    Chu, Chia-Yi
    Chung, Leland
    Freedland, Stephen
    Di Vizio, Dolores
    Garraway, Isla
    Murali, Ramachandran
    Knudsen, Beatrice
    Freeman, Michael
    CANCER RESEARCH, 2018, 78 (16) : 49 - 49
  • [6] Multimodal action of ONECUT2 in driving neuroendocrine prostate cancer
    Kaochar, Salma
    Mitsiades, Nicholas
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S198 - S203
  • [7] ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer
    Qian, Chen
    Yang, Qian
    Rotinen, Mirja
    Huang, Rongrong
    Kim, Hyoyoung
    Gallent, Brad
    Yan, Yiwu
    Cadaneanu, Radu M.
    Zhang, Baohui
    Kaochar, Salma
    Freedland, Stephen J.
    Posadas, Edwin M.
    Ellis, Leigh
    Di Vizio, Dolores
    Morrissey, Colm
    Nelson, Peter S.
    Brady, Lauren
    Murali, Ramachandran
    Campbell, Moray J.
    Yang, Wei
    Knudsen, Beatrice S.
    Mostaghel, Elahe A.
    Ye, Huihui
    Garraway, Isla P.
    You, Sungyong
    Freeman, Michael R.
    NUCLEIC ACIDS RESEARCH, 2024, 52 (13) : 7740 - 7760
  • [8] ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression
    Qingyang Ma
    Kai Wu
    Hui Li
    Huichun Li
    Yufei Zhu
    Guohong Hu
    Landian Hu
    Xiangyin Kong
    Scientific Reports, 9
  • [9] ONECUT2 overexpression promotes RAS-driven lung adenocarcinoma progression
    Ma, Qingyang
    Wu, Kai
    Li, Hui
    Li, Huichun
    Zhu, Yufei
    Hu, Guohong
    Hu, Landian
    Kong, Xiangyin
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [10] MicroRNA-1205 directly targets ONECUT2 in neuroendocrine prostate cancer cells.
    Dieujuste, Bachelard
    Naidoo, Michelle
    Ogunwobi, Olorunseun
    CANCER RESEARCH, 2021, 81 (13)